MEDIUM confidence
Researched 2026-07-28 13:10 · profile: researcher
Programme Thesis
The Chan Zuckerberg Initiative's Single-Cell Biology Data Insights program funds computational experts to develop tools and resources that extract deeper biological and clinical insights from single-cell datasets, aiming to accelerate discoveries in health and disease. It exists to bridge the gap between the growing volume of single-cell data and the analytical methods needed to interpret it, particularly for understudied populations and diseases.
Selection Criteria
- Scientific merit and innovation of the proposed computational tool or resource
- Relevance to advancing insights into health and disease from single-cell data
- Technical feasibility and clarity of the approach
- Open-source commitment and plan for community dissemination
- Track record of the applicant in computational biology or related fields
- Potential for broad impact and scalability across datasets
- Alignment with CZI's mission of open science and equity
Past Winners / Cohort Profiles
Past cohorts include computational biologists, bioinformaticians, and data scientists from academic institutions and nonprofits, often with expertise in single-cell genomics, machine learning, and software engineering. Named examples are not listed on the page, but typical winners have published tools like scVI, Scanpy, or CellRank, and have strong records of open-source contributions.
Ideal Candidate Fingerprint
The platonic ideal applicant is a computational biologist or data scientist with a proven track record of developing open-source tools for single-cell data analysis, such as dimensionality reduction, clustering, or trajectory inference. They have deep domain knowledge in cell biology or disease mechanisms, a history of publishing in peer-reviewed journals, and a clear plan to make their tool widely accessible and impactful.
Recommended Framing
Eniola should frame his application around his unique computational and data-engineering skills—specifically his DuckDB-based pipelines, Bayesian calibration, and ML models—as a foundation for building scalable, interpretable tools for single-cell data analysis. He can bridge his addiction neuroscience expertise (e.g., CCT model) to cellular-level insights by proposing to analyze single-cell transcriptomic data from reward-related brain regions, linking circuit-level pharmacology to cell-type-specific gene expression changes in addiction. This interdisciplinary angle leverages his strengths while directly addressing the program's goal of gaining insights into health and disease from single-cell data.
Watch Out
Eniola's primary research lines are not in single-cell biology, which may be seen as a lack of domain expertise. He has no published single-cell data analysis tools or papers, and his independent researcher status without a formal academic lab could raise concerns about institutional support and access to single-cell datasets. The program likely requires a strong computational biology background, which he partially meets, but his focus on addiction neuroscience and protein ML may be perceived as tangential.